gp130: a promising drug target for cancer therapy

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.11, 2013-11, pp. : 1303-1328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NEDD4: A Promising Target for Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 549-556

Bentham Science Publishers

Access to resources Recommend Favorite

gp130-mediated signalling as a therapeutic target

By Ohtani T. Ishihara K. Atsumi T. Yoshida Y. Nishida K. Narimatsu M. Shirogane T. Hibi M. Hirano T.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 459-479

Informa Healthcare

Access to resources Recommend Favorite

Entry Inhibitors Directed Towards Glycoprotein gp120: An Overview on a Promising Target for HIV-1 Therapy

Current Medicinal Chemistry, Vol. 20, Iss. 6, 2013-01 ,pp. : 751-771

Bentham Science Publishers

Access to resources Recommend Favorite

MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy

Current Cancer Drug Targets, Vol. 7, Iss. 3, 2007-05 ,pp. : 259-271

Bentham Science Publishers

Access to resources Recommend Favorite

p53 as a drug target in cancer therapy

By Chène Patrick

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 6, 2001-06 ,pp. : 923-935

Informa Healthcare

Access to resources Recommend Favorite